BCWORLD PHARM. Statistics

Total Valuation

BCWORLD PHARM. has a market cap or net worth of KRW 39.41 billion. The enterprise value is 117.92 billion.

Market Cap	39.41B
Enterprise Value	117.92B

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BCWORLD PHARM. has 8.44 million shares outstanding. The number of shares has decreased by -0.40% in one year.

Current Share Class	n/a
Shares Outstanding	8.44M
Shares Change (YoY)	-0.40%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.71%
Owned by Institutions (%)	n/a
Float	4.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.51
P/TBV Ratio	n/a
P/FCF Ratio	8.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.90, with an EV/FCF ratio of 25.74.

EV / Earnings	-17.10
EV / Sales	1.62
EV / EBITDA	13.90
EV / EBIT	133.96
EV / FCF	25.74

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.18.

Current Ratio	0.52
Quick Ratio	0.29
Debt / Equity	1.18
Debt / EBITDA	10.55
Debt / FCF	19.54
Interest Coverage	0.17

Financial Efficiency

Return on equity (ROE) is -8.15% and return on invested capital (ROIC) is 0.32%.

Return on Equity (ROE)	-8.15%
Return on Assets (ROA)	0.30%
Return on Capital (ROIC)	0.32%
Revenue Per Employee	256.90M
Profits Per Employee	-24.28M
Employee Count	284
Asset Turnover	0.40
Inventory Turnover	2.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.67%
50-Day Moving Average	4,971.50
200-Day Moving Average	5,827.23
Relative Strength Index (RSI)	31.44
Average Volume (20 Days)	5,922

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCWORLD PHARM. had revenue of KRW 72.96 billion and -6.90 billion in losses. Loss per share was -817.30.

Revenue	72.96B
Gross Profit	27.86B
Operating Income	880.27M
Pretax Income	-3.58B
Net Income	-6.90B
EBITDA	8.48B
EBIT	880.27M
Loss Per Share	-817.30

Full Income Statement

Balance Sheet

The company has 6.60 billion in cash and 89.55 billion in debt, giving a net cash position of -82.95 billion or -9,829.89 per share.

Cash & Cash Equivalents	6.60B
Total Debt	89.55B
Net Cash	-82.95B
Net Cash Per Share	-9,829.89
Equity (Book Value)	75.95B
Book Value Per Share	9,197.08
Working Capital	-41.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.29 billion and capital expenditures -2.71 billion, giving a free cash flow of 4.58 billion.

Operating Cash Flow	7.29B
Capital Expenditures	-2.71B
Free Cash Flow	4.58B
FCF Per Share	542.95

Full Cash Flow Statement

Margins

Gross margin is 38.19%, with operating and profit margins of 1.21% and -9.45%.

Gross Margin	38.19%
Operating Margin	1.21%
Pretax Margin	-4.91%
Profit Margin	-9.45%
EBITDA Margin	11.63%
EBIT Margin	1.21%
FCF Margin	6.28%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.14%.

Dividend Per Share	100.00
Dividend Yield	2.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.40%
Shareholder Yield	2.53%
Earnings Yield	-17.50%
FCF Yield	11.63%

Dividend Details

Stock Splits

The last stock split was on December 27, 2019. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 27, 2019
Split Type	Forward
Split Ratio	1.1

Scores

BCWORLD PHARM. has an Altman Z-Score of 0.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	n/a